CLINICAL_TRIALS
trial_result
· 2014-05-22
Clinical Trial Update: Clevidipine in the Treatment of Patients With Severe Hypertension (VELOCITY) [Phase 3]
Summary
The VELOCITY Phase 3 trial evaluating clevidipine for severe hypertension has completed. The sponsor is The Medicines Company.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: The Medicines Company | Conditions: Hypertension | Phase 3 | Status: COMPLETED